Literature DB >> 3655864

Reporting outcomes in Hodgkin's disease and lymphoma.

D O Dixon1, P McLaughlin, F B Hagemeister, E J Freireich, L M Fuller, F F Cabanillas, E A Gehan.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3655864     DOI： 10.1200/JCO.1987.5.10.1670

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19).

Authors:  M Herold; A Schulze; D Niederwieser; A Franke; H J Fricke; P Richter; M Freund; B Ismer; K Dachselt; C Boewer; V Schirmer; J Weniger; R Pasold; C Winkelmann; C Klinkenstein; M Schulze; H Arzberger; K Bremer; S Hahnfeld; A Schwarzer; C Müller; Chr Müller
Journal:  J Cancer Res Clin Oncol       Date:  2005-08-09       Impact factor: 4.553

Review 2.  Early stage Hodgkin's disease in adults: which is the correct treatment?

Authors:  M Brada
Journal:  Postgrad Med J       Date:  1989-11       Impact factor: 2.401

3.  Reproducibility of tumor response evaluation in patients with high-grade malignant non-Hodgkin's lymphoma.

Authors:  E Osby; A Taube; E Cavallin-Ståhl; H Hagberg; M Björkholm
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

4.  A pilot study of EVAP/ABV chemotherapy in 25 newly diagnosed children with Hodgkin's disease.

Authors:  H Ekert; T Fok; L Dalla-Pozza; K Waters; P Smith; L White
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.